Fundamentals of the ICP-MS Technique and How to Resolve Issues for Pharmaceutical Materials (In 20 Minutes)
Tim Shelbourn, Eli Lilly and Company
Fundamentals of the ICP-MS Technique and How to Resolve Issues for - - PowerPoint PPT Presentation
Fundamentals of the ICP-MS Technique and How to Resolve Issues for Pharmaceutical Materials (In 20 Minutes) Tim Shelbourn, Eli Lilly and Company Why ICP Mass Spectrometry? Ultra-trace multi-element analytical technique Ultra-Trace atomic
Tim Shelbourn, Eli Lilly and Company
Eli Lilly and Company 2
Eli Lilly and Company 3
Eli Lilly and Company 4
Dose, g 10 Specimen weight, g 0.2 Final Volume, mL 100 Class Element Parenteral PDE, µg/Day Permitted Conc., µg/g Control Threshold, µg/g Control Threshold Spike Conc., µg/L Experimental Spike Conc., µg/L 1 As 15 1.5 0.45 0.9 0.12 1 Cd 2 0.2 0.06 0.12 0.12 2A Co 5 0.5 0.15 0.3 0.12 3 Cu 300 30 9 18 2.4 1 Hg 3 0.3 0.09 0.18 0.12 3 Li 250 25 7.5 15 2.4 2A Ni 20 2 0.6 1.2 0.6 1 Pb 5 0.5 0.15 0.3 0.12 3 Sb 90 9 2.7 5.4 2.4 2A V 10 1 0.3 0.6 0.6
Eli Lilly and Company 5
Final Volume, mL 0.0 0.05 0.10 0.25 0.50 1.00 0.06 Final Volume, 2% HNO3 Element Stock Standard Conc., µg/mL Blank, µg/L Std 1, µg/L Std 2, µg/L Std 3, µg/L Std 4, µg/L Std 5, µg/L Spiking Conc., µg/L As 0.1 0.1 0.2 0.5 1 2 0.12 50 Cd 0.1 0.1 0.2 0.5 1 2 0.12 50 Co 0.1 0.1 0.2 0.5 1 2 0.12 50 Cu 2 2 4 10 20 40 2.4 50 Hg 0.1 0.1 0.2 0.5 1 2 0.12 50 Li 2 2 4 10 20 40 2.4 50 Ni 0.5 0.5 1 2.5 5 10 0.6 50 Pb 0.1 0.1 0.2 0.5 1 2 0.12 50 Sb 2 2 4 10 20 40 2.4 50 V 0.5 0.5 1 2.5 5 10 0.6 50 All test solutions contain 10ppb internal standard and 100ppb Au.
Eli Lilly and Company 6
Description 7Li, µg/L 45Sc IS (%) 51V, µg/L 59Co, µg/L 60Ni, µg/L 65Cu, µg/L 75As, µg/L 89Y IS (%) 114Cd, µg/L 115In IS (%) 123Sb, µg/L 159Tb IS (%) 175Lu IS (%) 202Hg, µg/L 208Pb, µg/L 209Bi IS (%) Sucrose Unspiked Average (n=3) 0.044 98 0.146 0.005 0.018 0.053 0.003 98 0.001 99 0.107 99 97 0.007 0.004 97 Sucrose Spiked Average (n=3) 2.381 99 0.692 0.126 0.629 2.507 0.135 97 0.124 99 2.521 98 97 0.131 0.127 98 Spiking Concentration 2.40 0.12 0.12 0.60 2.40 0.12 0.12 2.40 0.12 0.12 Sucrose Recovery, % 97 91 101 102 102 110 103 101 103 102 Description 7Li, µg/L 45Sc IS (%) 51V, µg/L 59Co, µg/L 60Ni, µg/L 65Cu, µg/L 75As, µg/L 89Y IS (%) 114Cd, µg/L 115In IS (%) 123Sb, µg/L 159Tb IS (%) 175Lu IS (%) 202Hg, µg/L 208Pb, µg/L 209Bi IS (%) NaCl Unspiked Average (n=3) 0.105 89 2.262 0.049 0.062 0.051 1.832 80 0.001 70 0.103 69 66 0.012 0.003 47 NaCl Spiked Average (n=3) 2.309 94 3.149 0.203 0.770 2.601 2.125 81 0.104 69 2.251 66 63 0.107 0.096 45 Spiking Concentration 2.40 0.12 0.12 0.60 2.40 0.12 0.12 2.40 0.120 0.120 NaCl %Recovery 92 148 128 118 106 244 86 90 79 77
sucrose.
Eli Lilly and Company 7 http://www.jsg.utexas.edu/icp-ms/files/Schematic.jpg
Eli Lilly and Company 8
Eli Lilly and Company 9
Eli Lilly and Company 10
Element STD Mode Slope (CPS/µg/L) KED Mode Slope (CPS/µg/L) STD Mode BEC, µg/L KED Mode BEC, µg/L Cd 104991 45105 0.00049 0.00052 Pb 338524 290879 0.00424 0.00440 As 28870 3368 0.00970 0.00330 Hg 47252 42875 0.00143 0.00215 Co 243487 63625 0.00139 0.00028 V 233273 20815 0.01435 0.00059 Ni 52487 17862 0.00781 0.00690 Li 141966 219 0.61960 0.59361 Sb 68504 19923 0.00307 0.00335 Cu 46749 20362 0.01940 0.02276
Eli Lilly and Company 11
Description 7Li, µg/L 45Sc IS (%) 51V, µg/L 59Co, µg/L 60Ni, µg/L 65Cu, µg/L 75As, µg/L 89Y IS (%) 114Cd, µg/L 115In IS (%) 123SbIS (%) 159Tb IS (%) 175Lu IS (%) 202Hg, µg/L 208Pb, µg/L 209Bi IS (%) Average Sucrose Unspiked (n=3) 0.198 101 0.011 0.003 0.015 0.113 -0.004 100 0.003 100 0.048 100 100 0.005 0.006 101 Average Sucrose Spiked (n=3) 2.409 102 0.601 0.121 0.609 2.502 0.120 100 0.122 100 2.447 99 100 0.123 0.126 101 Spike Concentration 2.40 0.60 0.12 0.60 2.40 0.12 0.12 2.40 0.12 0.12 %Recovery 92 98 98 99 100 104 99 100 98 100 Description 7Li, µg/L 45Sc IS (%) 51V, µg/L 59Co, µg/L 60Ni, µg/L 65Cu, µg/L 75As, µg/L 89Y IS (%) 114Cd, µg/L 115In IS (%) 123SbIS (%) 159Tb IS (%) 175Lu IS (%) 202Hg, µg/L 208Pb, µg/L 209Bi IS (%) Average NaCl Unspiked (n=3) 0.291 142 0.033 0.004 0.039 0.065
111 0.002 93 0.029 88 85 0.006 0.005 59 Average NaCl Spiked (n=3) 2.906 145 0.933 0.155 0.737 2.633 0.143 111 0.104 93 2.326 87 85 0.096 0.094 58 Spike Concentration 2.40 0.60 0.12 0.60 2.40 0.12 0.12 2.40 0.12 0.12 %Recovery 109 150 126 116 107 119 85 96 75 74
Why does the internal standard response trend downward with increased analyte mass in NaCl?
Eli Lilly and Company 12
Description 7Li, µg/L 45Sc IS (%) 51V, µg/L 59Co, µg/L 60Ni, µg/L 65Cu, µg/L 75As, µg/L 89Y IS (%) 114Cd, µg/L 115In IS (%) 123SbIS (%) 159Tb IS (%) 175Lu IS (%) 202Hg, µg/L 208Pb, µg/L 209Bi IS (%) Average NaCl Unspiked (n=3) 0.291 142 0.033 0.004 0.039 0.065
111 0.002 93 0.029 88 85 0.006 0.005 59 Average NaCl Spiked (n=3) 2.906 145 0.933 0.155 0.737 2.633 0.143 111 0.104 93 2.326 87 85 0.096 0.094 58 Spike Concentration 2.40 0.60 0.12 0.60 2.40 0.12 0.12 2.40 0.12 0.12 %Recovery 109 150 126 116 107 119 85 96 75 74 Description 7Li, µg/L 45Sc IS (%) 51V, µg/L 59Co, µg/L 60Ni, µg/L 65Cu, µg/L 75As, µg/L 89Y IS (%) 114Cd, µg/L 115In IS (%) 123Sb, µg/L 159Tb IS (%) 175Lu IS (%) 202Hg, µg/L 208Pb, µg/L 209Bi IS (%) Average NaCl Unspiked (n=3)
0.034
111 0.002 93 0.031 88 85 0.010 0.010 59 Average NaCl Spiked (n=3) 1.683 145 0.624 0.109 0.517 1.903 0.108 111 0.103 93 2.351 87 85 0.143 0.151 58 Spike Concentration 2.40 0.60 0.12 0.60 2.40 0.12 0.12 2.40 0.12 0.12 % Recovery 70 101 89 82 79 90 84 98 111 118 Only 115In IS Corrected: Corrected by Interpolation between ISs by mass:
Eli Lilly and Company 13
Element Ionization Potential (eV) Isotopes (amu) Abundance (%) Li 5.39 6 7.52 7 92.48 Lu 5.43 175 97.4 176 2.6 In 5.79 113 4.16 115 95.84 Tb 5.85 159 100 Pb 6.11 204 1.37 206 25.15 207 21.11 208 52.38 Y 6.38 89 100 Sc 6.54 45 100 V 6.74 50 0.24 51 99.76 Bi 7.29 209 100
Eli Lilly and Company 14
Element Ionization Potential (eV) Isotopes (amu) Abundance (%) Ni 7.63 58 67.76 60 26.16 61 1.25 62 3.66 64 1.16 Cu 7.73 63 69.09 65 30.91 Sb 7.85 121 57.25 123 42.75 Co 7.86 59 100 Cd 8.99 106 1.22 108 0.89 110 12.43 111 12.86 112 23.79 113 12.34 114 28.81 116 7.66 As 9.81 75 100 Hg 10.44 196 0.146 198 10.02 199 16.84 200 23.13 201 13.22 202 29.8 204 6.85
Eli Lilly and Company 15
No IS Correction: Description 7Li, µg/L 45Sc IS (%) 51V, µg/L 59Co, µg/L 60Ni, µg/L 65Cu, µg/L 75As, µg/L 89Y IS (%) 114Cd, µg/L 115In IS (%) 123Sb, µg/L 159Tb IS (%) 175Lu IS (%) 202Hg, µg/L 208Pb, µg/L 209Bi IS (%) Average NaCl Unspiked (n=3) 0.108 142
0.005
111
93
88 85
59 Average NaCl Spiked (n=3) 2.585 145 0.851 0.141 0.665 2.365 0.128 111 0.092 93 2.075 87 85 0.084 0.082 58 Spike Concentration 2.4 0.6 0.12 0.6 2.4 0.12 0.12 2.4 0.12 0.12 %Recovery 103 142 117 110 99 107 77 86 70 68 Selected IS Correction: Description 7Li, µg/L 45Sc IS (%) 51V, µg/L 59Co, µg/L 60Ni, µg/L 65Cu, µg/L 75As, µg/L 89Y IS (%) 114Cd, µg/L 115In IS (%) 123Sb, µg/L 159Tb IS (%) 175Lu IS (%) 202Hg, µg/L 208Pb, µg/L 209Bi IS (%) Average NaCl Unspiked (n=3) 0.291 142 0.015 0.004 0.033 0.065
111 0.003 93 0.038 88 85 0.010 0.010 59 Average NaCl Spiked (n=3) 2.906 145 0.604 0.132 0.623 2.633 0.120 111 0.110 93 2.467 87 85 0.143 0.151 58 Spike Concentration 2.4 0.6 0.12 0.6 2.4 0.12 0.12 2.4 0.12 0.12 %Recovery 109 98 107 98 107 100 90 101 111 118
Eli Lilly and Company 16